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Abstract
Background: Epidemiological studies have illustrated that exposure to atmospheric nitrogen oxides 
(NO2/NOX) is responsible for an increased risk of acute or chronic diseases such as cancer. In this 
study the health risks associated with nitrogen dioxide (NO2) were assessed in the city of Kermanshah, 
the capital of Kermanshah province, Iran. 
Methods: Data on hourly NO2 levels that had been measured with the Environ tech model M200 was 
taken from the Kermanshah Environmental Protection Agency (KEPA). The AirQ2.2.3 model was 
used to quantify data based on baseline incidence (BI), relative risk (RR), and attributable proportion 
(AP). The number of cases of cardiovascular mortality (CM), acute myocardial infarction (MI), and 
hospital admissions for chronic obstructive pulmonary diseases (HACOPD) was estimated.
Results: The results of the current study show that there were 33, 16, and 13 cases of CM, acute MI, 
and HACOPD, respectively, attributable to NO2 exposure. Furthermore, 26.85% of health impacts 
occurred on days when NO2 levels did not exceed 40 µg/m3. For every 10 µg/m3 increase in the NO2 
level, the risk of CM, MI, and HACOPD rose about 0.2%, 0.36%, and 0.38%, respectively.
Conclusion: In order to reduce the number of cases of mortality and morbidity caused by exposure to 
NO2, several immediate steps should be taken by the government to control emissions from various 
sources, particularly car exhaust, to reduce the levels of NO2 in the atmosphere. 
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Introduction
Air pollution due to industrialization and urbanization is 
one of the major environmental issues of the current cen-
tury, especially in developing countries (1-4). Because of 
its adverse effects on human health, exposure to air pollu-
tion is related to increased rates of mortality and morbidi-
ty (5-8). Air pollution is a mixture of different atmospher-
ic pollutants such as particulate matter, nitrogen dioxide 
(NO2), carbon monoxide, ozone, sulfur dioxide, etc (7,9). 
In recent decades, researchers have considered short-term 
and long-term exposure to air pollutants and the outcome 
of such exposure on human health (10-12). Among dif-
ferent atmospheric pollutants, NO2 is a gas with oxidant 
properties that is capable of diminishing the air quality in 
many urban and industrial contexts as well as the indoor 
air of homes with domestic combustion devices. Nitrogen 
oxide (NO) is the main precursor of NO2 in the presence 
of atmospheric oxidants such as ozone (O3). In polluted 
air, NO can be quickly oxidized by O3 and then converted 
into NO2 through a photochemical reaction (13-16). The 
main source of NO2 in the urban atmosphere is gas re-
leased from road traffic. Other anthropogenic sources of 
NO2 include power stations, fossil fuels, waste incinerates, 
industrial boilers, and household heaters. Furthermore, 
the major sources of NO2 in indoor environments are nat-
ural gas cookers and smoke resulting from burning ciga-
rettes (14,17). According to the results of epidemiological 
studies in Europe and around the world, approximately 
5%-7% of lung cancer cases among ex-smokers and non-
smokers can be associated with exposure to high levels 
of air pollutants containing NO2 or being in the proxim-
ity of roads with heavy traffic (17,18). A few studies have 
demonstrated that short-term exposure to NO2 can cause 
mortality in exposed populations because of cardiovascu-
lar diseases (14,19). Jenkins et al stated that exposure to 
an NO2 level of 400 ppb for 3 hours alone or in combina-
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tion considerably increased sensitivity to inhaled allergens 
compared with contact to air without additive effects (20). 
Some epidemiological studies have indicated that ambient 
air pollution is related to cardiovascular diseases, espe-
cially myocardial infarction (MI) (21). Acute MI is a seri-
ous sickness that typically leads to death and increases the 
health costs of a society. Goudarzi et al demonstrated the 
association between increasing NO2 levels and acute MI 
among people in Ahvaz, Iran (22). Chronic obstructive 
pulmonary disease (COPD) is an inflammatory airway 
disease. NO2 is a slight soluble gas that is maintained in 
the small airways of the lungs. Thus, patients with COPD 
or asthma attacks are more sensitive to low levels of NO2 
(23). Ghozikali et al showed that approximately 0.9% of 
total hospitalizations associated with COPD resulted from 
exposure to NO2 (18). Fattore et al showed that exposure 
to atmospheric NO2 caused cardiovascular mortality 
(CM) in the inhabitants of the cities of Mazzano and Rez-
zato, Italy (14). Because of the effects of air pollution on 
human health demonstrated by data from various stud-
ies, the World Health Organization (WHO), European 
governments, and other associations have started shap-
ing environmental policies to investigate the impacts of 
atmospheric pollution on public health (24,25). Another 
study by Yang et al showed an association between hospi-
tal admissions and an increase of 32 μg/m3 in NO2 concen-
tration in the air of Kaohsiung, Taiwan (26). The current 
study assessed the health impacts of exposure to NO2 on 
the inhabitants of Kermanshah, Iran during 2014-2015.
Methods
Study area
Kermanshah (34˚19ʹN, 47˚7ʹE), the capital city of Ker-
manshah province, is located in western Iran. It has a 
population of about 870 000 persons and is the ninth most 
crowded city in Iran. It is well-known for its cultural sites 
and monuments and is also a good passage for transpor-
tation between Iran and Iraq. Kermanshah is one of the 
most polluted cities in Iran because of several huge in-
dustrial factories such as petrochemical refinery and Ker-
manshah Oil Refining Company (KORC) that are located 
in the center of the city (27) and also because of the high 
number of automobiles (28) (see Figure 1). One air pol-
lution-monitoring station situated in Ziba Park and Ker-
manshah Environmental Protection Agency (KEPA) were 
responsible for measuring NO2 concentrations in the air. 
The hourly NO2 concentrations for one year, from March 
2014 to March 2015, were taken from the KEPA for use in 
the present study.
Relative risk and baseline incidence 
The Air Quality Health Impact Assessment (AirQ2.2.3) 
software was developed to calculate the health effects 
of short-term contact with atmospheric pollutants on a 
resident population in a specific area for one year. In epi-
demiological studies, relative risk (RR) is the increase in 
chances of developing a sickness caused by exposure to 
a pollutant. The values of RR (per 10 µg/m3) defined by 
the WHO and baseline incidence (BI, per 100 000 people) 
associated with different types of mortality and morbidity 
cases are shown in Table 1. The amounts of RR and related 
BI have been extracted from AirQ2.2.3 data files devel-
oped by the WHO European Center for Environment and 
Health based on various conducted peer-reviewed studies 
(29,30).
Standardization of NO2 data
The Environ tech model M200 was used to measure NO2. 
This system continuously monitored atmospheric NO2 
concentrations and involved a cross-flow modulated 
semi-decompression chemiluminescence method. Raw 
data obtained from KEPA was based on volumetric unit 
(ppm or ppb), while the AirQ software accepted data 
based on gravimetric units (µg/m3). Thus for conversion, 
the data from air quality monitoring was saved in a Mi-
crosoft Excel spreadsheet. All processing mechanisms for 
converting volumetric data to gravimetric units and other 
processes include averaging, coding, modifying pressure 
and temperature, and data filtering were carried out using 
the mentioned software. For filtering, the data was sorted 
into averages of diurnal concentrations, briefed by sorting 
amounts from lower to higher, and then the number of 
days in the range of NO2 concentrations were identified. 
Data was converted by the ideal gas formula presented in 
Eq. 1:
P1V1/T1 = P2V2/T2                                                                                                             (1)
Figure 1. Kermanshah city and sampling station.
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where parameters of P1, V1, and T1 are the initial pressure, 
volume, and absolute temperature, respectively. Also, 
P2, V2, and T2 are the final amounts of pressure, volume, 
and absolute temperature under standard conditions, 
respectively. 
Concentration response equations
The AirQ2.2.3 software model was proposed by the WHO 
for assessing potential outcomes of exposure to different 
pollutants in the atmosphere on the health of people liv-
ing in a given place and period (5). The estimation was 
based on the population attributable risk proportion (AP) 
defined as the portion of the health effect on a specified 
inhabitant exposed for a certain time to a specific atmo-
spheric pollutant (14,31). The AP can be estimated using 
Eq. (2):
{[ ( ) 1] ( )} / [ ( ) ( )]AP RR c P c RR c P c= ∑ − × ∑ ×                   (2)
where AP is the attributable proportion of the health end-
point and RR(c) is the RR for certain human health effect 
in category “c” (e.g., residential or industrial) of contact 
that can be obtained from the exposure-response func-
tions taken from different studies. P(c) is the exposed 
group of people (5,14). 
The rate attributable to the exposure can be estimated us-
ing the following equation, if the baseline frequency of the 
health effect in the population under evaluation has been 
determined:
IE = I × AP                                                                            (3)
where IE and I are the rate of the health impact attribut-
able to the exposure and the BI of the health effect on in-
vestigated inhabitants, respectively. If the population rate 
is known, the number of estimated excess cases associated 
with the exposure may be calculated using Eq. (4):
NE = IE × N                                                                          (4)
where NE is the number of excess persons associated with 
the contact and N is the number of people under study. 
Input adjustment 
Mortality and morbidity cases were assessed by running 
the AirQ model version: 2.2.3. The different parameters 
were considered, and concentration intervals of NO2 were 
recorded into 10 µg/m3 categories related to equivalent ex-
posure categories. The model assumes that the NO2 mea-
sured data is representative of the mean exposure of the 
people. Finally, the cumulative numbers of excess cases 
for CM, acute MI, and HACOPD were detected using 
AirQ2.2.3 software based on RR and BI presented above 
in Table 1.
Results
The annual average, annual maximum, summer and win-
ter averages, summer and winter maximums, and 98th 
percentile of NO2 concentration taken from running the 
AirQ2.2.3 software are illustrated in Figure 2. Obviously, 
the annual average concentration of NO2 in Kermanshah 
was equal to 75.76 µg/m3. The average summer NO2 level 
was 63.08 µg/m3, which is lower than the winter average 
of 77.34 µg/m3. The maximum annual NO2 concentration 
was observed in the winter with a concentration of 198.42 
µg/m3. This value was higher than the summer concentra-
tion with a maximum of 142.93 µg/m3.
Table 2 illustrates the association between percentages 
of the population attributable risk (AP) and the cumula-
tive number of excess cases of exposure to atmospheric 
NO2 among people of Kermanshah. As seen, the cumula-
tive numbers of CM, MI, and HACOPD cases in a central 
RR and AP percentages of 1.20%, 2.15%, and 2.27% per 
100 000 people were estimated to be 33, 16, and 13 per-
sons, respectively. According to the model’s default for 
NO2, in low RR (RR=1), the value of estimated AP is zero. 
Therefore, the cumulative number of excess cases for CM 
is zero.
Figure 3 shows the results of quantifying the health out-
comes of exposure to NO2 in Kermanshah obtained from 
the model. This figure illustrates diagrams based on the 
Table 1. RR with 95% Cl used for investigating the health effects of 
NO2
Health effect BI RR (95% Cl) per 10 µg/m3
Mortality CM 497 1.0020 (1.00-1.0040) (14)
Morbidity Acute MI 132 1.0036 (1.0015-1.0084) (17)
HACOPD 101.4 1.0038 (1.0004-1.0094) (18)
Abbreviations: RR, relative risk; NO2, nitrogen dioxide; BI, baseline 
incidence; CM, cardiovascular mortality; HACOPD, hospital admissions 
for chronic obstructive pulmonary diseases; MI, myocardial infarction.
Figure 2. The highest and the lowest concentrations of NO2 in 
Kermanshah.
Table 2. Estimated AP percentages and number of excess cases due 
to short-term exposure to NO2 levels above 10 µg/m
3
Health effects Estimated AP (%) NO. of excess cases 
CM 1.2085 (0.000-2.3881) 33 (0.0-65)
Acute MI 2.1515 (0.9091-4.8867) 16 (7-35)
HACOPD 2.2715 (0.2441-5.4369) 13 (2-30)
Abbreviations: NO2, nitrogen dioxide; CM, cardiovascular mortality; 
HACOPD, hospital admissions for chronic obstructive pulmonary 
diseases; MI, myocardial infarction; AP, attributable proportion. 
a Taken from the lower and upper of RR amounts.
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cumulative number of each health outcome and the cu-
mulative number of estimated excess cases at the low, mid-
dle, and upper ranges (5%, 50%, and 95%), respectively. In 
the three curves of RR (associated with upper, central, and 
lower) in each diagram, the upper curve corresponded to 
a 95% RR (overestimate), the idle curve related to the cen-
tral RR, and the lower curve corresponded to a 5% of RR 
(underestimate). The cumulative numbers of 30.7, 14.6, 
and 11.7 cases of CM, MI, and HACOPD, respectively, can 
be attributed to exposure concentrations of NO2 above 40 
µg/m3. The results also showed that about 1.2% (95% CI: 
0.00%-2.4%) of CM, 2.2% (95% CI: 0.91%-4.5%) of MI, 
and 2.3% (0.24%-5.4%) of HACOPD cases were attributed 
to NO2 levels over 10 µg/m3. With each increase of 10 µg/
m3 in NO2 level, the risk of CM, MI, and HACOPD rises 
about 0.2%, 0.36%, and 0.38%. Also, 92.33% of health end-
points of exposure to NO2 occurred on days with levels 
over 10 µg/m3. Furthermore, 26.85% of health outcomes 
happened in days with NO2 concentrations not exceeding 
40 µg/m3.
Discussion
In this study, the method suggested by the WHO for as-
sessing health impacts of atmospheric pollutants was used 
to investigate the effects of short-term exposure to NO2 
on the health of Kermanshah inhabitants, one of the most 
densely populated cities of western Iran. For this objec-
tive, AirQ2.2.3 software was applied. This tool has been 
used in several epidemiological studies around the world 
to evaluate the health effects attributable to NO2 on mor-
tality and morbidity rates (5,6,14,17,32). Three ranges of 
RR (lower, central, and upper ranges) were considered 
for each endpoint based on the default of AirQ software. 
The annual, summer, and winter averages of NO2 levels 
were 75.76, 63.08, and 77.34 µg/m3, respectively. The pri-
mary standard for NO2 published by National Ambient 
Air Quality Standard (NAAQS) is 100 µg/m3. The current 
WHO air quality guideline recommends an annual aver-
age concentration of 40 µg/m3 for NO2 exposure. Statis-
tical analysis showed that the annual average of NO2 in 
Kermanshah was lower than the value recommended by 
NAAQS but higher than the WHO guideline. The annual, 
summer, and winter maximums and the 98th percentile of 
NO2 were equal to 198.42, 142.93, 198.42, and 160.78 µg/
m3, respectively. These values were determined in a simi-
lar study (51.53, 37.29, 66.32, 179.54, 106.01, 179.54, and 
130.03 µg/m3) in Ahvaz, Iran (17) and are approximately 
consistent with the findings of the present study. The an-
nual maximum NO2 concentration was observed in win-
ter with a value of 198.42 µg/m3, which is higher than the 
summer maximum level (142.93 µg/m3). This increase can 
be associated with the use of gas fuel for heating homes 
 
 
 
Fig. 3. Relationship between cumulative number of health effects and NO2 concentrations 
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In this study, the method suggested by the WHO for assessing health impacts of atmospheric 
pollutants was used to investigate the effects of short-term exposure to NO2 on the health of 
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and the stability of the atmosphere during the winter sea-
son (17). The maximum percentage of days that people 
in Kermanshah were exposed to different levels of NO2 
during one year (from March 2014 to March 2015) was 
detected in the concentration range of 50-59 µg/m3. The 
cumulative number of excess cases for CM, MI, and HA-
COPD based on corresponding BI values per one hundred 
thousand people as defined by the WHO, in central RR 
and estimated AP were estimated to be 1.208%, 2.151%, 
and 2.271% (33, 16, 13 persons), respectively. The cumu-
lative number of excess cases for CM and MI were also 
investigated in 2011-2012 in Kermanshah (17) and found 
to be equal to 44 and 17 persons, respectively. This result 
shows reductions of about 25% and 5.8% in mortality and 
morbidity cases due to exposure to NO2 compared with 
the findings of the current study. The cumulative number 
of HACOPD cases caused by exposure to NO2 in Tabriz, 
Iran was 11.6 persons (33). This number is lower than the 
results of the current study. In APs equal to 1.8%, 2.4%, 
and 2.2%, the cumulative number of CM and respiratory 
mortality cases in Rezzato, Italy were 2.4 and 2.2 persons 
due to exposure to NO2 during one year, respectively (14). 
NO2 is most retained in the small airways of the lungs, 
because it is not highly soluble and thus has a greater air-
way deposition. It remains a pollutant of current concern. 
In many experimental studies, there was a relationship 
between COPD and more sensitive to NO2 than healthy 
control subjects (23). In another study in Suwon city, the 
number of CM in the BI value of 84.5 per 105 people and 
in the centerline RR (RR = 1.004) was estimated to be 23.9 
persons (9). That number is lower than the results of the 
current study. For the population of more than 870 000 in 
Kermanshah, about 13, 6.2, and 5 cases of mortality due 
to CM, MI, and HACOPD annually can be attributed to 
NO2 levels higher than 100 µg/m3. In another study in 
Tabriz, the rates of mortality and morbidity caused by 
exposure to NO2 in a population of one and a half mil-
lion persons were assessed. The results illustrated that the 
cumulative numbers of excess cases for mortality because 
of cardiovascular diseases, MI, and HACOPD were 34.2, 
16.3, and 13.2 persons (18), which is consistent with the 
estimated results of the current study. CM had the low-
est RR in the central group (RR = 1.0020) compared with 
MI (RR = 1.0036) and HACOPD (RR = 1.0038), but a high 
number of these health effects were because of a higher 
BI quantity (497 per 10 000 persons). The results of the 
present study illustrate that 1.2% (95% CI: 0.0%-2.4%) of 
CM, 2.2% (95% CI: 0.91%-4.5%) of MI, and 2.3% (95% CI: 
0.24%-5.4%) of HACOPD were attributed to exposure to 
NO2 concentrations higher than 10 µg/m3. In an APHEA 
project in Europe, the short-term impacts of air pollution, 
such as HACOPD, were evaluated. The RR for a 50 µg/m3 
increase in the diurnal average of NO2 concentration was 
1.02% (95% CI: 1.00%-1.05%) (34). In another study, an 
increase in NO2 levels was associated with an 11% increase 
in daily hospitalizations for cardiorespiratory diseases 
(35). In Sao Paulo, Brazil, the atmospheric NO2 had a sig-
nificant relationship with increased HACOPD (36). For 
each 10 µg/m3 increase in the NO2 level, the risk of CM, 
MI, and HACOPD rose about 0.2%, 0.36%, and 0.38%, 
respectively. In Bushehr, Iran, each 10 µg/m3 increase of 
NO2 concentration led to an increased risk of mortality 
and morbidity cases of about 0.4% in the year 2011-2012 
(17). In another study in Tabriz, the results showed that 
with each 10 µg/m3 increase in NO2 concentration, the risk 
of HACOPD increased 0.38% during 2008-2009 (37). In 
Toronto, Canada, study results illustrated that there were 
7.7 cases of COPD hospitalization, 40.4% of which were 
because of exposure to NO2 (38). The results of this study 
showed that 7.67% of the health endpoints attributed to 
NO2 occurred on days with pollutant levels not exceeding 
20 µg/m3. In Ahvaz, Iran, 82% of MI cases occurred on 
days with an atmospheric NO2 level of less than 110 µg/m3 
(22). In the present study, 87.12% of MIs occurred in NO2 
levels not exceeding 110 µg/m3. In Shiraz, Iran NO2 had 
a positive correlation with respiratory deaths in persons 
aged 18 to 60 years (39). A rapid slope in the NO2 level 
range of less than 110 µg/m3 is observable. This slope is 
attributed to the fast increase of the number of mortality 
and morbidity cases due to exposure to different concen-
trations of NO2 in Kermanshah. These recent findings are 
in agreement with those of 2011-2012 study conducted in 
Kermanshah (17). 
Limitations
In this suggested approach, the study only focused on 
the health effects of a single pollutant without regarding 
the simultaneous contact with other contaminants. The 
interactions between different pollutants are not well 
evaluated. Moreover, since AirQ is an ecologically-based 
method and not an epidemiological approach, it does not 
consider intra-individual differences within the people in-
vestigated.
Conclusion
According to the current results, there was a decrease in 
the cumulative number of mortality and morbidity cases 
in Kermanshah for 2014-2015 compared with 2011-2012 
due to lower NO2 concentrations or to a decrease in the 
number of days in which people were exposed to high NO2 
concentrations. The results of this study are in line with 
those of previous studies; they illustrate this approach, 
and the software offers an easy and valuable model which 
is helpful in decision-making. Although the results are 
consistent with other studies throughout the world, more 
studies with specific or national RR and BI values based on 
climate, geographical, and statistical features are required. 
There is a need to prevent various source emissions, es-
pecially automobile exhaust, to reduce NO2 levels in the 
atmosphere. To reduce the health endpoints of exposure 
to NO2, health training should be performed for the pub-
lic, especially for vulnerable individuals, to advise them to 
reduce their activity levels on polluted days. An attempt 
should be made by governmental bodies to control emis-
sions from various sources, particularly from car exhaust, 
to reduce the concentration of NO2 in the atmosphere. 
Omidi et al
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